Showing Filtered Articles

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B; EMPA-REG OUTCOME Investigators

N Engl J Med. 2016 Jul 28;375(4):323-34. doi: 10.1056/NEJMoa1515920
Categories:
  • Diabetic Kidney Disease
  • General Nephrology
  • Tags:
  • Visual Abstract
  • Pubmed Journal Link Visual Abstract Download / Comments
    Google Plus
    LinkedIn

    A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

    Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators

    N Engl J Med. 2009 Nov 19;361(21):2019-32
    Categories:
  • Anemia
  • Tags:
  • Randomized Trial
  • Visual Abstract
  • Pubmed Journal Link Visual Abstract Download / Comments
    Google Plus
    LinkedIn

    Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

    Edmund J. Lewis, M.D., Lawrence G. Hunsicker, M.D., William R. Clarke, Ph.D., Tomas Berl, M.D., Marc A. Pohl, M.D., Julia B. Lewis, M.D., Eberhard Ritz, M.D., Robert C. Atkins, M.D., Richard Rohde, B.S., and Itamar Raz, M.D., for the Collaborative Study G

    N Engl J Med. 2001 Sep 20;345(12):851-60
    Categories:
  • Diabetic Kidney Disease
  • Tags:
  • Randomized Trial
  • SHSC
  • Visual Abstract
  • Pubmed Journal Link Visual Abstract Download / Comments
    Google Plus
    LinkedIn
    Total items found: 4
    Suggest an Article or Abstract

    For suggested articles, Simply enter an article's PubMed ID number and our reviewers will consider the article for addition to the archive. Otherwise, attach a PDF below. You may also submit a visual abstract for consideration

    Or
    Add files